BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36002246)

  • 21. Review of patients with basal cell nevus syndrome.
    Taylor SF; Cook AE; Leatherbarrow B
    Ophthalmic Plast Reconstr Surg; 2006; 22(4):259-65. PubMed ID: 16855496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same.
    Huq AJ; Walsh M; Rajagopalan B; Finlay M; Trainer AH; Bonnet F; Sevenet N; Winship IM
    Fam Cancer; 2018 Oct; 17(4):601-606. PubMed ID: 29356994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of genetic loci for basal cell nevus syndrome and inflammatory bowel disease in a single large pedigree.
    Panhuysen CI; Karban A; Knodle Manning A; Bayless TM; Duerr RH; Bailey-Wilson JE; Epstein EH; Brant SR
    Hum Genet; 2006 Aug; 120(1):31-41. PubMed ID: 16733713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of keratocystic odontogenic tumor cell lines derived from sporadic and basal cell nevus syndrome patients.
    Noguchi K; Wakai K; Kiyono T; Kawabe M; Yoshikawa K; Hashimoto-Tamaoki T; Kishimoto H; Nakano Y
    Int J Oncol; 2017 Dec; 51(6):1731-1738. PubMed ID: 29039452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the Sonic Hedgehog receptor "PATCHED" in basal cell carcinomas and odontogenic keratocysts.
    Zedan W; Robinson PA; Markham AF; High AS
    J Pathol; 2001 Aug; 194(4):473-7. PubMed ID: 11523056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous Keratocyst With D2-40 Immunoreactivity in Basal Cell Nevus Syndrome.
    Goggins CA; Zerah ML; Anatelli F; Norton SA
    Am J Dermatopathol; 2021 Sep; 43(9):659-661. PubMed ID: 33606372
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Ponti G; Manfredini M; Pastorino L; Maccaferri M; Tomasi A; Pellacani G
    Anticancer Res; 2018 Jan; 38(1):471-476. PubMed ID: 29277811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic Stability in Syndromic Basal Cell Carcinoma.
    Chiang A; Jaju PD; Batra P; Rezaee M; Epstein EH; Tang JY; Sarin KY
    J Invest Dermatol; 2018 May; 138(5):1044-1051. PubMed ID: 29111235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of calretinin in odontogenic keratocysts and basal cell carcinomas: A study of sporadic and Gorlin-Goltz syndrome-related cases.
    Cesinaro AM; Burtini G; Maiorana A; Rossi G; Migaldi M
    Ann Diagn Pathol; 2020 Apr; 45():151472. PubMed ID: 31982676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.
    Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG
    J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal cell naevus syndrome: an update on genetics and treatment.
    John AM; Schwartz RA
    Br J Dermatol; 2016 Jan; 174(1):68-76. PubMed ID: 26409035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AKT1 Activation is Obligatory for Spontaneous BCC Tumor Growth in a Murine Model that Mimics Some Features of Basal Cell Nevus Syndrome.
    Kim AL; Back JH; Zhu Y; Tang X; Yardley NP; Kim KJ; Athar M; Bickers DR
    Cancer Prev Res (Phila); 2016 Oct; 9(10):794-802. PubMed ID: 27388747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New mutations and an updated database for the patched-1 (PTCH1) gene.
    Reinders MG; van Hout AF; Cosgun B; Paulussen AD; Leter EM; Steijlen PM; Mosterd K; van Geel M; Gille JJ
    Mol Genet Genomic Med; 2018 May; 6(3):409-415. PubMed ID: 29575684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basaloid follicular hamartomas in pediatric Basal Cell Nevus Syndrome: A diagnostic challenge.
    Besagni F; Dika E; Ricci C; Misciali C; Veronesi G; Corti B; Gurioli C; Neri I
    J Dermatol; 2021 Jul; 48(7):1101-1105. PubMed ID: 34021633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meningiomas after medulloblastoma irradiation treatment in a patient with basal cell nevus syndrome.
    Campbell RM; Mader RD; Dufresne RG
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S256-9. PubMed ID: 16227103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biallelic disruption of the PTCH1 gene in multiple basal cell carcinomas in Japanese patients with nevoid basal cell carcinoma syndrome.
    Tate G; Kishimoto K; Mitsuya T
    Acta Med Okayama; 2014; 68(3):163-70. PubMed ID: 24942795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acrochordon-like basal cell carcinomas in patients with basal cell nevus syndrome.
    Lortscher DN; Sengelmann RD; Allen SB
    Dermatol Online J; 2007 May; 13(2):21. PubMed ID: 17498440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic determinants of basal cell carcinoma risk.
    Epstein E
    Med Pediatr Oncol; 2001 May; 36(5):555-8. PubMed ID: 11340611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidisciplinary Approach for Treating Malocclusion of Patient With Basal Cell Nevus Syndrome: A Case Report.
    Inoue S; Kurosaka H; Lee D; Yamashiro T
    Cleft Palate Craniofac J; 2020 Feb; 57(2):255-262. PubMed ID: 31382775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resolution of odontogenic keratocysts of the jaw in basal cell nevus syndrome with GDC-0449.
    Goldberg LH; Landau JM; Moody MN; Kazakevich N; Holzer AM; Myers A
    Arch Dermatol; 2011 Jul; 147(7):839-41. PubMed ID: 21422324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.